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Artemisinin merupakan ubat antimalaria yang sangat berkesan dan 
digunakan secara meluas kerana keupayaannya dalam membunuh parasit 
Plasmodium dengan pantas. Namun, artemisinin telah dilaporkan mempunyai kurang 
kerentanan terhadap P. falciparum di Asia Tenggara menyebabkan permintaan 
kepada ubat antimalaria baru yang mempunyai cara tindakan serupa dengan 
artemisinin. Sehingga kini, mekanisme tindakan artemisinin yang tepat masih 
dipertikaikan walaupun penyelidikan telah dijalankan berdekad lamanya. Bukti 
terbaru menunjukkan artemisinin mempunyai perencatan terus terhadap pam proton, 
ATPase-H
+
 Jenis-V yang terletak pada membran vakuol pencernaan parasit, di mana 
perencatan tersebut menyebabkan perubahan pH dalam organel berasid itu. Oleh itu, 
pH vakuol pencernaan parasit yang dirawat dengan artemisinin diukur dalam kajian 
ini menggunakan sitometri aliran. Asai berasaskan sitometri aliran telah 
dioptimumkan untuk mengukur pH vakuol pencernaan menggunakan penunjuk pH 
bersifat ratiometrik iaitu, fluorescein isothiocyanate-dextran (FITC-dextran) 
dimuatkan ke dalam vakuol pencernaan parasit. Satu lengkung penentukuran pH 
dijana dengan menggunakan parasit pada peringkat trofozoit yang dipencilkan dan 
diampaikan dalam larutan penimbal yang berbeza pH dengan kehadiran ionofor, 
carbonyl cyanide m-chlorophenylhydrazone (CCCP). Tanpa CCCP, keadaan stabil 
pH vakuol pencernaan berada pada nilai 5.42 ± 0.11. Seterusnya, aktiviti antimalaria 
artemisinin dinilai menggunakan asai rawatan selama 4 jam (memimikkan 
xx 
 
pendedahan in vivo) bagi menentukan kepekatan perencatan sebanyak 50% (IC50-4 
jam) dan kepekatan sub-maut (menyebabkan kematian parasit kurang dari 25%). 
Parasit pada peringkat cincin pertengahan dirawat menggunakan kepekatan 
artemisinin yang berbeza (0-10000 nM) selama 4 jam dan dilarutkan dengan media 
bagi menyingkirkan artemisinin. Kultur parasit terus dikulturkan selama 24 jam 
untuk pemerhatian terhadap pertumbuhan parasit dan 48 jam untuk memeriksa 
kebolehhidupan parasit. Kepekatan sub-maut (15 dan 30 nM) dipilih daripada kajian 
ini untuk memastikan perubahan pH vakuol pencernaan yang dilihat dalam 
eksperimen seterusnya bukan disebabkan kematian parasit. Dengan menggunakan 
asai rawatan 4-jam keatas parasit pada peringkat cincin pertengahan, kepekatan sub-
maut meningkatkan pH vakuol pencernaan sebanyak 0.49 (15 nM, pH = 5.7 ± 0.1) 
dan 1.56 unit pH (30 nM, pH = 6.77 ± 0.48), apabila dibandingkan dengan parasit 
yang tidak dirawat (pH = 5.21 ± 0.04). Asai yang sama juga dilakukan keatas parasit 
pada peringkat trofozoit pertengahan untuk membolehkan pengukuran terus pH 
vakuol pencernaan. pH vakuol pencernaan telah meningkat sebanyak 1 (15 nM, pH = 
6.6 ± 0.1) dan 1.48 unit pH (30 nM, pH = 7.1 ± 0.08), apabila dibandingkan dengan 
parasit yang tidak dirawat (pH = 5.6 ± 0.1). Keputusan perubahan pH vakuol 
pencernaan yang sama disebabkan oleh perencat ATPase-H
+
 Jenis-V, concanamycin 
juga dapat dilihat (pH = 7.4 ± 0.1). Kesimpulannya, keputusan tersebut menunjukkan 
artemisinin seperti concanamycin A berupaya merencat ATPase-H
+
 Jenis-V yang 
menyebabkan perubahan pH di dalam vakuol pencernaan. Asai berasaskan sitometri 
aliran dalam kajian ini menyediakan model yang mudah dan tepat untuk pengukuran 
pH vakuol pencernaan serentak dengan penilaian pertumbuhan parasit dan 
kebolehhidupan selepas rawatan dengan menggunakan ubat antimalaria yang lain.     
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Artemisinin, a highly potent antimalarial drug is widely used due to the 
rapid killing of Plasmodium parasites. However, artemisinin has been reported to 
have reduced susceptibility against P. falciparum in Southeast Asia demanding for 
new antimalarial drugs that have a similar mode of action with artemisinin. To date, 
the precise mechanism of action of artemisinin remains disputable despite decades of 
research. Recent evidence showed that artemisinin might have a direct inhibition of 
proton pump, V-type H
+
-ATPase located on the membrane of parasite’s digestive 
vacuole, in which the inhibition causes pH alteration in the acidic organelle. Hence, 
the pH of the digestive vacuole of parasites treated with artemisinin was measured in 
this study by using flow cytometry. The flow cytometry-based assay was optimised 
to measure the digestive vacuole pH using a ratiometric pH indicator, fluorescein 
isothiocyanate (FITC)-dextran loaded into the parasite’s digestive vacuole. A 
standard pH calibration curve is generated by using the isolated trophozoite stage 
parasites suspended in buffers with different pH in the presence of an ionophore, 
carbonyl-cyanide m-chlorophenylhydrazone (CCCP). Without CCCP, the steady-
state digestive vacuole pH showed an acidic value of 5.42 ± 0.11. Next, the 
antimalarial activity of artemisinin was evaluated by using a 4-hour drug pulse assay 
to determine the 50% inhibitory concentration (IC50-4 hours) and sub-lethal concentrations 
(caused less than 25% parasite death). Mid ring stage parasites were pulsed with 
different concentrations of artemisinin (0-1000 nM) for 4 hours (mimic in vivo 
xxii 
 
exposure) and then washed to remove the drugs. The parasite cultures were 
continually cultured for 24 hours to examine its growth and 48 hours to examine its 
viability. Sub-lethal concentrations (15 and 30 nM) were selected from this study to 
ensure the digestive vacuole pH change observed in the subsequent experiment was 
not due to parasite death. Using the similar assay of 4-hour drug pulse on mid ring 
stage parasites, the sub-lethal concentrations increased the digestive vacuole pH by 
0.49 (15 nM, pH = 5.7 ± 0.1) and 1.56 pH unit (30 nM, pH = 6.77 ± 0.48), 
respectively as compared with the untreated parasites (pH = 5.21 ± 0.04). The same 
assay was performed at mid trophozoite stage parasites to enable direct measurement 
of the digestive vacuole pH. The pH of the digestive vacuole was increased by 1 (15 
nM, pH = 6.6 ± 0.1) and 1.48 pH unit (30 nM, pH = 7.1 ± 0.08), respectively as 
compared with the untreated parasites (pH = 5.6 ± 0.1). A similar result of the 
digestive vacuole pH alteration caused by a standard V-type H
+
-ATPase inhibitor, 
concanamycin A was observed (pH = 7.4 ± 0.1). In conclusion, the result showed 
that artemisinin, like concanamycin A may inhibit the V-type H
+
-ATPase, which 
caused the pH alteration in the digestive vacuole. The flow cytometry-based assay in 
this study provides a simple and accurate model for the measurement of digestive 
vacuole pH with a simultaneous evaluation on parasite growth and viability 




CHAPTER 1  
INTRODUCTION 
 
1.1 Background of the study 
 
Malaria is a global health issue and remains a prominent infectious 
disease in developing countries especially in tropical and subtropical regions. In 
2017, approximately 219 million malaria cases were reported worldwide with an 
estimated 435 000 deaths (World Health Organization (WHO), 2018). In Malaysia, a 
total of 508 cases including local and imported cases were recorded in 2017 (WHO, 
2018). The influxes of foreign workers especially from malaria endemic countries 
have contributed to the recurrence of the cases and the widespread of the disease 
(Yong et al., 2018). Hence, massive efforts and strategies are warranted to eliminate 
malaria. 
  
Malaria is generally transmitted to humans through the bites of infected 
female Anopheles mosquitoes. The disease can also be transmitted via blood 
transfusion or sharing needles contaminated with the parasite. There are five species 
of the human malaria parasites namely Plasmodium falciparum, P. vivax, P. ovale, P. 
malariae and P. knowlesi. Among these species, P. falciparum is the most virulent 
and responsible for the highest rate of morbidity and mortality of malaria worldwide 
(Geleta and Ketema, 2016). 
 
Plasmodium falciparum has a multistage life cycle to complete its growth 
and development in different hosts (Aly et al., 2009). The sexual cycle of the malaria 
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parasite occurs in a mosquito, which involves the production of infective sporozoites. 
The sporozoites enter the human host during the blood feeding, initiating the asexual 
cycle. The asexual cycle of the parasite involves two main phases; the 
exoerythrocytic and intraerythrocytic phases. The exoerythrocytic phase begins when 
the sporozoites enter the bloodstream and invade the hepatocytes. After maturation 
of live-stage schizonts, thousands of merozoites are released from the bursting of the 
hepatocytes. The merozoites subsequently invade the erythrocytes, initiating the 
intraerythrocytic phase. At this phase, the parasite takes approximately 48 hours to 
complete its pathogenic life cycle, which is responsible for the clinical 
manifestations of the disease (Josling and Llinás, 2015). 
 
Common clinical symptoms caused by the malaria parasites grown in the 
erythrocytes are headache, fever, vomiting, muscle pain and diaphoresis. These mild 
symptoms can progress into severe illness such as severe anaemia and cerebral 
malaria, which can cause death without immediate and proper treatment (Trampuz et 
al., 2003; White, 2018). To date, the chemotherapeutic treatment using antimalarial 
drugs remains the primary option to combat malaria as there is no effective vaccine 
available thus far (Mahmoudi and Keshavarz, 2017).  
 
Chloroquine, an antimalarial drug from the class of 4-aminoquinolines, 
was the most prescribed drug for malaria treatment (Al-Bari, 2015). Due to the 
emergence and spread of parasite populations resistant to this drug, this has led to the 
discovery of endoperoxide-containing compounds, artemisinin and its derivatives 
(Rudrapal and Chetia, 2016). These promising drugs have a superior activity against 
all intraerythrocytic stage parasites (Mohd-Zamri et al., 2017a) and have been used 
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together with other drugs that have long-lasting effects in artemisinin-based 
combination therapies (ACTs) (Pinheiro et al., 2018). Currently, ACTs have been 
recommended as the first-line treatment for uncomplicated malaria (WHO, 2010). 
Worryingly, the decline in susceptibility of artemisinin against the parasites was 
reported in Southeast Asia countries such as in Thailand and Cambodia and 
manifested clinically as longer parasite clearance time (Fairhurst and Dondorp, 2016; 
Hanboonkunupakarn and White, 2016). Thus, it is important to understand the 
precise mode of action of artemisinin in a view to reveal the key drug target within 
the parasite. 
 
The precise mechanism of action of artemisinin is still a matter of debate 
among researchers over the decades. Although several parasite proteins have been 
reported to be the drug targets (Wang and Lin, 2016), none of them could 
satisfactorily account for the rapid and potent inhibitory effect of artemisinin. A 
recent proteomics study by Wang et al. (2015) identified several parasite proteins as 
the targets of artemisinin including V-type H
+
- pyrophosphatase. Another study by 
Ismail et al. (2016), also demonstrated that two subunits A and B of the V-type H
+
-
ATPase are the targets of artemisinin. V-type H
+
-pyrophosphatase and V-type H
+
-
ATPase have been shown to act together to maintain a low internal pH of the 
digestive vacuole of the malaria parasite (Hapuarachchi et al., 2017; Saliba et al., 
2003). We hypothesised that artemisinin might have a direct effect on the digestive 
vacuole’s proton pumps, thereby causing the alkalinisation of this organelle and 
eventually the parasite death. The present study was conducted to measure the pH of 
the digestive vacuole of the parasites treated with artemisinin and its correlation with 
parasite growth and viability. 
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1.2 Rationale of the study  
 
The malaria parasite spends part of its life cycle inside the erythrocyte. 
Using cytostomes, the parasite performs endocytosis to internalise the haemoglobin 
(Dluzewski et al., 2008; Milani et al., 2015). Budding of the cytostomes leads to the 
formation of haemoglobin-containing endocytic vesicles (Lazarus et al., 2008). 
These vesicles are transferred to the digestive vacuole for degradation by proteases 
(Abu Bakar et al., 2010). Several proteases involved in the haemoglobin degradation 
are aspartic, cysteine and metalloproteinases that work optimally in the pH ranging 
from 4.5-5.5 (Liu, 2017b; Na et al., 2010), suggesting that the digestive vacuole 
maintains an acidic environment. 
 
The maintenance of the acidic pH of the digestive vacuole has been 
regulated by the action of the proton pumps, V-type H
+
-ATPase and V-type H
+
- 
pyrophosphatase located at the digestive vacuole’s membrane (Hapuarachchi et al., 
2017; Shah et al., 2016). These proton
 
pumps have been responsible to promote the 
influx of H
+
 into the digestive vacuole (Abu Bakar, 2015). The inhibition of V-type 
H
+
-ATPase and V-type H
+
-pyrophosphatase by specific inhibitors such as 
concanamycin A and imidodiphosphate (IDP) respectively caused the alkalinisation 
of the digestive vacuole (Shah et al., 2016).  
 
The ultrastructural study by del Pilar Crespo et al. (2008) using serial 
thin-section transmission electron microscopy showed that treatment with 
artemisinin (40 times the IC50 values of the drug) for 8 hours caused the disruption of 
the digestive vacuole’s membrane. The authors also observed using fluorescence 
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microscopy the cellular distribution of the pH probe (LysoSensor Blue) in the 
digestive vacuole, suggesting an early disruption of the pH gradient. However, it is 
still obscure whether this was due to the primary action of artemisinin or as the 
consequence of parasite death due to higher concentration of artemisinin and longer 
treatment with the drug. 
 
To address the question, in the present study, a flow cytometry-based 
assay was developed for a quantitative analysis of pH of the digestive vacuole of 
parasites pulsed for 4 hours with sub-lethal concentrations of artemisinin by using a 
pH-sensitive fluorescent probe, fluorescein isothiocyanate (FITC)-dextran. Flow 
cytometry offers an alternative technique for evaluating pH changes of the digestive 
vacuole on a population of erythrocytes and permits direct correlation with parasite 
growth (Abu Bakar, 2015; Ibrahim and Abu-Bakar, 2019). A DNA/RNA-binding 
fluorescent dye, SYBR Green I that takes advantage of the absence of nucleic acids 
in mature erythrocytes was used with flow cytometry to discriminate between 
infected and uninfected erythrocytes. This significantly facilitates direct and 
correlative measurements between multiple parameters, which are digestive vacuole 
pH and parasite growth and survival. Parasites were exposed to a short 4-hour pulse 
with different concentrations of artemisinin to mimic the duration of clinical 
exposure to the drug, which has a short half-life. The 4-hour pulse inhibitory 
concentration 50%  (IC50-4 hours) and the sub-lethal concentrations of the drug that 
caused less than 25% parasite death were determined and employed throughout  
subsequent experiments. The study might be able to explain the action and specificity 
of artemisinin in parasite killing and facilitate the development of better strategies to 
treat malaria in times of emerging resistance to artemisinin. 
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1.3 Objectives of the study 
 
1.3.1 General objective 
   
To determine pH changes of the digestive vacuole of the chloroquine-sensitive (3D7) 
strain of P. falciparum treated with sub-lethal concentrations of artemisinin in the 4-
hour pulse drug inhibition assay 
 
1.3.2 Specific objectives 
 
i. To determine optimal loading concentration of FITC-dextran in resealed 
erythrocytes 
ii. To generate a standard pH calibration curve using saponin-permeabilised 
parasites containing FITC-dextran 
iii. To determine the 4-hour pulse inhibitory concentration 50% (IC50-4 hours) and 
sub-lethal concentrations of artemisinin against mid ring stage parasites. 
iv. To measure the pH of the digestive vacuole of the parasite pulsed for 4 hours 
with sub-lethal concentrations of artemisinin and its correlation with parasite 
growth 
 
1.4 Experimental design  
 
The aim of the study was to measure the pH of the digestive vacuole of 
the malaria parasite pulsed for 4 hours with sub-lethal concentrations of artemisinin. 
The digestive vacuole pH was measured using a ratiometric pH indicator, FITC-
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dextran incorporated into resealed erythrocytes using a method of hypotonic 
haemolysis dilution. Beforehand, an optimal loading concentration of FITC-dextran 
was determined to detect sufficient fluorescence signal while minimising the loss of 
haemoglobin during the resealing process. Ring stage parasites were treated with 
sorbitol to obtain a synchronous population of mature stage parasites at 26-hour post-
synchronisation. Mature stage parasites were harvested using a magnetic column 
separation technique and cultured with resealed erythrocytes.  
 
The invasion of early ring stage parasites in resealed erythrocytes was 
observed at 14-hour post-inoculation (~6-hour post-invasion). After 42-hour post-
inoculation (~34-hour post-invasion), trophozoite stage parasites with accumulated 
FITC-dextran within the digestive vacuole were isolated by brief exposure with 
0.035% (w/v) saponin. Saponin-permeabilised parasites were incubated in different 
pH buffers in the presence of an ionophore, causing the pH of the parasite 
compartments to equilibrate with the pH of the buffers. A pH calibration curve was 
generated based on the ratio of the fluorescence intensity of FITC-dextran measured 
at two different wavelengths (530 nm and 585 nm). This standard curve was used for 
determination of pH of the parasite’s digestive vacuole.  
 
Next, the assay of 4-hour artemisinin pulse was performed for the 
assessment of parasite growth and viability. Mid ring stage parasites were pulsed for 
4 hours (to mimic the drug’s short half-life in human body) with different 
concentrations of artemisinin prepared by two-fold serial dilutions. After 4 hours, the 
parasite cultures were washed to remove the drug and incubated in normal culture 
conditions for additional 24 and 48 hours. The effects of the treatment were 
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evaluated at 24-hour post-treatment (to assess parasite growth and parasitaemia in the 
same cycle) and at 48-hour post-treatment (to examine the parasite viability in the 
next cycle) using SYBR Green I staining. The increase of parasitaemia calculated at 
48-hour post-treatment represents the parasite viability. The percentage of parasite 
growth inhibition was measured based on the parasitaemia at 24- and 48-hour post-
treatment for determination of the 4-hour pulse inhibitory concentration 50% (IC50-4 
hours). The sub-lethal concentrations of artemisinin that caused less than 25% parasite 
death and affected the parasite growth were selected to be employed in the 
subsequent experiment. 
 
In the experiment to measure the pH of the digestive vacuole, mid ring 
stage parasites in resealed erythrocytes with and without FITC-dextran were pulsed 
with sub-lethal concentrations of artemisinin for 4 hours. Like in the 4-hour 
artemisinin pulse assay, the parasite cultures were washed to remove the drug and 
further cultured for 24 and 48 hours. At 24-hour post-treatment, parasite with FITC-
dextran-containing digestive vacuoles was isolated with saponin (0.035% w∕v) for 
digestive vacuole pH measurement by flow cytometry. Parasite cultures using 
resealed erythrocytes without FITC-dextran were split into two aliquots before being 
used for the assessment of parasite growth at 24-hour post treatment and parasite 
viability at 48-hour post-treatment. The assay of 4-hour drug pulse with sub-lethal 
concentrations was also performed at mid trophozoite stage parasites to enable direct 
measurement of the digestive vacuole pH. The summarised flow for the study is 























Figure 1.1: Flowchart of the experiments throughout the study 
 
A pH calibration curve was established using the ratiometric pH indicator, FITC-
dextran incorporated into the saponin-permeabilised parasites. The pH calibration 
curve was used to measure the digestive vacuole pH. The sub-lethal concentrations 
were determined in the assay of 4-hour artemisinin pulse. These concentrations were 
employed in the subsequent experiment using the same assay of 4-hour drug pulse to 
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 LITERATURE REVIEW 
 
2.1 Overview of malaria 
 
Malaria is a lethal infectious disease, which has been a scourge of 
humanity since ancient times. The causative agents of the disease are malaria 
parasites of the genus Plasmodium that can be transmitted by female mosquitoes of 
the genus Anopheles. After the discovery of the malaria parasite in the human 
erythrocyte in 1880 by Laveran (Hanboonkunupakarn and White, 2016),  many 
studies have been extensively carried out as malaria has been widely spread 
throughout many countries in the world. Various strategies and efforts including the 
use of insecticide-treated bed nets, indoor residual spraying and antimalarial drugs 
have contributed to the control and elimination of the disease (Tizifa et al., 2018). 
Due to the problem of drug resistance, malaria still remains a major health issue 
especially in Southeast Asia and other tropical regions in the world (Cui et al., 
2015). 
 
2.2 Distribution of malaria 
 
Malaria mostly occurs in tropical and sub-tropical countries where 
temperature, humidity and rainfall are relatively high and suitable for parasite growth 
and development within the mosquitoes (Kar et al., 2014). To date, 91 countries 
have ongoing malaria transmission with most cases and deaths occur in Africa 
(WHO, 2018). According to WHO (2018), most malaria cases in 2017 were reported 
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in the African region with 200 million cases (92%) followed by the Southeast Asia 
region (5%) and the Eastern Mediterranean region (2%). Fifteen countries in sub-
Saharan Africa and India were responsible for almost 80% of the malaria cases 
worldwide with five countries namely Nigeria (25%), Democratic Republic of the 
Congo (11%), Mozambique (5%), India (4%) and Uganda (4%) accounted for nearly 
half of the total malaria statistics worldwide (Figure 2.1).  
 
In Malaysia, there has been a tremendous reduction in malaria burden in 
the past two decades (WHO, 2018). Even there was a fluctuation of malaria cases in 
2005-2009 (Figure 2.2), the number of cases gradually decreased in 2010. The 
number of malaria cases in 2017 continually dropped to 508 cases including the 
cases of P. vivax, P. falciparum and imported cases. However, there was an increase 
of the total malaria cases in 2017 due to P. knowlesi infection. Sabah and Sarawak 
have contributed to the majority of P. knowlesi cases in Malaysia followed by 
several states in Peninsular Malaysia (Yong et al., 2018). 
 
2.3 Human malaria parasites   
 
The phylum Apicomplexa comprises of diverse obligate intracellular 
parasites of the genus Plasmodium, Babesia, Toxoplasma, Cryptosporidium, Eimeria 
and Theileria (Reid, 2015). There are about 200 species of Plasmodium and five of 
them are identified to cause infection in human namely P. falciparum, P. vivax, P. 















Figure 2.1: The malaria incidence rates worldwide from 2000-2017 
 
All countries in the European region and China reported zero indigenous cases in 2017. Certain regions such as in Southeast Asia are still in 




                                
Figure 2.2: The number of malaria cases in Malaysia from 2005-2017 
 
The number of malaria cases increased in 2008 with the highest cases was from P. vivax. The cases of P. vivax and P. falciparum decreased in 
the following years. In 2017, the total cases showed a slight increase due to the cases of P. knowlesi. Modified from WHO (2018).  
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Plasmodium knowlesi has been always misdiagnosed as P. malariae by 
microscopic examination. Now, the advancement of tools used for diagnosing 
malaria is able to differentiate the genetic components between these two species 
(Mohring et al., 2019). P. malariae has the ability to persist in the intraerythrocytic 
stage for a long time, but does not cause a hypnozoite infection (Grossman et al., 
2017). The hypnozoites can be observed in P. ovale and P. vivax infections, which 
are able to remain dormant in the liver cells up to several months or years and can 
cause a relapse infection (Okafor and Finnigan, 2019). 
   
Among the five human malaria parasites, P. falciparum is responsible for 
the vast majority of mortality and morbidity worldwide where it is predominantly 
distributed in sub-Saharan Africa (Howes et al., 2016). P. falciparum is the most 
virulent malaria parasite that can cause high parasitaemia and able to invade host 
erythrocytes of different ages (Geleta and Ketema, 2016).  
 
2.4 Life cycle of the malaria parasite 
  
The malaria parasite has a complex life cycle that alternates between a 
sexual cycle in a mosquito vector and an asexual cycle in a human host.  
 
2.4.1 Sexual cycle of the malaria parasite within a mosquito 
 
The sexual cycle of the malaria parasite commences when a female 
mosquito ingests microgametocytes (male) and macrogametocytes (female) from an 


















      
Figure 2.3: The sexual cycle of the malaria parasite within a mosquito 
 
Microgametocytes (male) and macrogametocytes (female) are ingested by a 
mosquito during a blood meal and delivered to the mosquito’s midgut. These 
gametocytes undergo maturation into microgametes and macrogametes. The 
microgametes fuse with the macrogametes forming zygotes, which undergo meiosis 
to form ookinetes. The ookinetes penetrate the midgut wall and mature into oocysts. 
The oocysts rupture releasing numerous sporozoites, which migrate to the salivary 








Exflagellation of the microgametocytes leads to the production of eight 
microgametes, which can fuse with macrogametes to produce zygotes in the 
mosquito’s midgut. The zygotes undergo meiosis to form motile ookinetes, which 
penetrate the midgut wall and differentiate into oocysts. After ten days of maturation, 
the oocysts rupture releasing numerous sporozoites. The sporozoites travel to the 
salivary gland where they are ready to be transmitted to a human during another 
blood meal. 
 
2.4.2 Asexual cycle of the malaria parasite within a human 
 
The asexual cycle of the malaria parasite begins when a mosquito 
inoculates sporozoites into a human during a blood feeding. The sporozoites enter the 
blood circulation and invade the liver cells to initiate the exoerythrocytic cycle 
(Figure 2.4A) (Josling and Llinás, 2015). Inside the liver cell, the parasite multiplies 
and matures into a schizont. The schizont ruptures releasing numerous merozoites. 
The exoerythrocytic cycle takes place between 2-7 days depending on the species of 
the malaria parasite (Bertolino and Bowen, 2015). The merozoites enter the blood 
circulation and invade the erythrocytes to initiate the intraerythrocytic cycle (Figure 
2.4B). Inside the erythrocyte, the parasite develops into three distinct stages; ring, 







                  
Figure 2.4: The asexual cycle of the malaria parasite within a human 
 
(A) Sporozoites inoculated by an infected mosquito enter the liver cells of a human 
host to begin the exoerythrocytic stage. The parasites mature into schizonts, which 
burst to release thousands of merozoites. (B) The intraerythrocytic stage is initiated 
after the merozoites invade erythrocytes. The parasites mature into ring, trophozoite 
and schizont stages. The mature schizonts burst to release merozoites, which 
reinvade new erythrocytes and repeat the same cycle. Some of the merozoites 
differentiate into male and female gametocytes that can be ingested by a mosquito 
thus completing the life cycle. Modified from Karunamoorthi (2014). 
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In the early ring stage, the central region of the parasite is quite thin, 
while the peripheral region is thicker and contains nucleus and other organelles 
(Poostchi et al., 2018). This gives its characteristic ring appearance in Giemsa-
stained blood smears (Figure 2.5A). The ring stage of P. falciparum lasts for 24 
hours from the time of merozoite invasion during which the metabolic activity and 
DNA levels are relatively low (Wallqvist et al., 2016). In the trophozoite stage, the 
parasite rapidly grows with an increase in the metabolic activity and RNA levels 
(Wallqvist et al., 2016). The parasite becomes globular with an enlarged cytoplasm 
where the digestive vacuole is readily observed by the accumulation of haemozoin 
pigment (Figure 2.5B). The trophozoite stage lasts for 10-12 hours in duration (25-38 
hour post-invasion). The trophozoite progresses to the schizont stage (38-48 hour 
post-invasion) (Figure 2.5C) and undergoes multiple rounds of mitotic DNA 
replication to produce 16-20 merozoites that are capable of invading new 
erythrocytes (De Niz et al., 2016). 
 
The rapid growth and development within the erythrocytes require the 
parasites to obtain nutrients and metabolise various biological molecules in order to 
survive and reproduce (Abshire et al., 2017). A better understanding of the parasite’s 
metabolisms such as haemoglobin metabolism may lead to the development of novel 














Figure 2.5: The intraerythrocytic stages of P. falciparum 
 
(A) After invasion, the ring stage parasite lasts for 24 hours before grow to (B) the 
trophozoite stage. The parasite becomes enlarged and globular with the appearance 
of haemozoin in the digestive vacuole. This stage lasts for 25-38 hours post-invasion 
before develop to (C) the schizont stage (38-48 hours post-invasion) where nuclear 
division occurs to produce a multinucleated schizont. The schizont ruptures releasing 
numerous merozoites, which will invade new erythrocytes to repeat the same 
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2.5 Haemoglobin metabolism within the malaria parasite 
 
The malaria parasite internalises a large portion of the cellular content of 
its host erythrocyte (Sigala and Goldberg, 2014). The internalised cytoplasm 
consisting largely of haemoglobin is transported to the digestive vacuole (Milani et 
al., 2015) where it is digested to provide amino acids for protein synthesis (Jonscher 
et al., 2019) and space for growth (Wendt et al., 2016).  
 
2.5.1 Haemoglobin ingestion by the malaria parasite 
 
The malaria parasite ingests the erythrocyte cytoplasm in spite of being 
enclosed within the parasitophorous vacuole (PV) (Santi-Rocca and Blanchard, 
2017). During the early ring stage of development, the haemoglobin ingestion is 
thought to be limited (Heller and Roepe, 2018). When the parasite enters the mid 
ring stage, small portions of the erythrocyte cytoplasm are taken up by 
micropinocytosis (Abu Bakar et al., 2010; Xie et al., 2016) . This process involves 
structures called cytostomes that are formed by double-membrane invaginations of 
the parasitophorous vacuolar membrane (PVM) and the parasite plasma membrane 
(PPM) (Figure 2.6A) (Milani et al., 2015). The protein composition of cytostomes is 
not known, but it has been shown that the endocytic process is mediated by actin 
(Jonscher et al., 2019; Lazarus et al., 2008). As the parasite matures to the 
trophozoite stage, a larger volume of haemoglobin is ingested by cytostomes (Abu 
Bakar et al., 2010; Wendt et al., 2016). There is evidence for continuing 









Figure 2.6: The schematic diagram of haemoglobin ingestion, transport to 
and digestion in the digestive vacuole of P. falciparum 
 
(A) Haemoglobin is internalised by the parasite via a cytostome. (B) The budding of 
the cytostome forms a double-membrane vesicle, which is directly transported to the 
digestive vacuole. (C) The outer membrane of the vesicle fuses with the digestive 
vacuole releasing haemoglobin. (D) Haemoglobin is degraded to amino acids and a 
toxic by-product haem. Haem is detoxified to an inert polymer known as haemozoin 
by the process of biocrystallisation. PVM: parasitophorous vacuolar membrane, 








eventually consumes 80% of the erythrocyte haemoglobin and occupies most of the 
erythrocyte volume (Silva et al., 2017). 
 
Other distinct mechanisms that mediate the haemoglobin uptake have 
been proposed (Elliott et al., 2008; Medeiros et al., 2012; Wendt et al., 2016). The 
early ring stage parasite was thought to fold around a big gulp of the erythrocyte 
cytoplasm to take up haemoglobin. This endocytic process was continued by small 
cytostome-derived haemoglobin-containing vesicles and tubules as the parasite 
matures. Additional cytostome-independent endocytic structures called phagosomes 
were described in more mature stage parasites. On the other hand, another study 
proposed that extended cytostomal tubes were used by the parasite to internalise and 
transfer haemoglobin to the digestive vacuole via a vesicle-independent process 
(Lazarus et al., 2008). However, live-cell imaging and photobleaching technique to 
investigate the dynamics and connectivity of different endocytic compartments did 
not support the role of the macropynocytic event in the parasite (Abu Bakar et al., 
2010; Liu et al., 2019). 
 
2.5.2 Haemoglobin transport to the digestive vacuole 
  
In the late ring stage of development, haemoglobin transport commences 
after cytostomes pinch off at the neck forming double-membrane, haemoglobin-
containing vesicles (Klemba et al., 2004; Milani et al., 2015) (see Figure 2.6B). The 
transport of haemoglobin-containing vesicles has been demonstrated to utilise an 
actin-myosin motor system (Milani et al., 2015). The haemoglobin and inner 
membrane of the vesicles have been shown to be digested by proteases and 
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phospholipases, respectively en route to the digestive vacuole (Abu Bakar et al., 
2010; Burda et al., 2015). The outer membrane of the vesicles has been reported to 
fuse with the plasma membrane of the digestive vacuole (Milani et al., 2015) (see 
Figure 2.6C), resulting in the delivery of single-membrane, haemoglobin-filled 
vesicles into the lumen of the digestive vacuole (Jonscher et al., 2019). A knockout 
of the gene encoding the P. falciparum digestive vacuole’s aspartic protease, 
plasmepsin IV (PfPM4) caused abundant accumulation of electron-dense vesicles in 
the digestive vacuole (Liu et al., 2015). Once the digestive vacuole is fully formed, it 
appears to be the primary site of haemoglobin degradation and haem detoxification 
 
2.5.2(a) The digestive vacuole of the malaria parasite 
 
The digestive vacuole is formed de novo after each round of infection of 
the erythrocyte by the malaria parasite (Wendt et al., 2016). The lack of the typical 
lysosomal acid phosphatase and glycosidases (Coronado et al., 2014) has proved that 
the digestive vacuole of the malaria parasite is a specialised organelle that evolves to 
efficiently digest haemoglobin (Deshpande and Kuppast, 2016). The digestive 
vacuole has also been observed in other parasites such as in Babesia caballi and 
Theileria equi (Maji, 2018).  
 
Microscopically, the alteration of the density of the digestive vacuole 
indicates that haemoglobin digestion has occurred (Wendt et al., 2016). This process 
produces an insoluble toxic waste product called haem, which is detoxified by the 
formation of haematin dimers that biocrystallise to a chemically inert malaria 
pigment known as haemozoin (Xie et al., 2016). Haemozoin can be observed by light 
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and electron microscopy as it is a very dense structure and lined up along a single 
axis in the parasite (Figure 2.7). Lipid bodies, whose contents are possibly derived 
from the digestive vacuole’s wall and interior as well as the inner membrane of the 
transport vesicles, are also found adjacent to the digestive vacuole (Olafson et al., 
2015). These neutral lipid bodies have been suggested to promote haematin 
formation (Olafson et al., 2015) and histidine-rich protein II (HRPII) (Gupta et al., 
2017). 
 
2.5.3 Haemoglobin digestion in the digestive vacuole 
 
In the digestive vacuole, haemoglobin that comprises of 95% of the 
cytosolic erythrocyte protein is digested by proteases via an ordered process (see 
Figure 2.6D) (Liu, 2017a). Haemoglobin has been initially digested by aspartic 
proteases (plasmepsins) and cysteine proteases (falcipains) into haem and globin 
(Coronado et al., 2014). Globin has been further hydrolysed by metalloprotease 
(falcilysin) to release amino acids for incorporation into parasite proteins as the 
parasite has a restricted capability to synthesise amino acids de novo (Pandey and 
Pandey-Rai, 2015). The inhibition of plasmepsins and falcipains by a combination of 
the aspartic protease inhibitor, pepstatin and the cysteine protease inhibitor, E-64 was 
led to the accumulation of undigested haemoglobin indicating a complete inhibition 
of haemoglobin digestion (Klonis et al., 2011; Milani et al., 2015). Haemoglobin 
digestion is also crucial to create space for parasite growth and to generate osmolytes 
to prevent premature lysis of the erythrocytes (Kumari et al., 2019). Like in 
lysosomes of mammalian cells and yeast vacuoles, pH homeostasis of the digestive  
 
